Community-acquired bacterial meningitis in adults

New England Journal of Medicine

Volumn 354, Issue 1, 2006, Pages 44-53

  Van De Beek, Diederik ^a   De Gans, Jan ^a   Tunkel, Allan R ^b   Wijdicks, Eelco F M ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MONMOUTH MEDICAL CENTER   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN; CORTICOSTEROID; DEXAMETHASONE; DOPAMINE; HEPARIN; INOTROPIC AGENT; INSULIN; MANNITOL; MILRINONE; OSMOTIC DIURETIC AGENT; PENICILLIN G; PROTON PUMP INHIBITOR; SODIUM CHLORIDE; VANCOMYCIN;

AIRWAY; ANASTOMOSIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ASSISTED VENTILATION; BACTERIAL MENINGITIS; BRAIN HERNIA; CEREBROSPINAL FLUID DRAINAGE; CLINICAL TRIAL; CONSCIOUSNESS LEVEL; CRYSTALLOID; DEEP VEIN THROMBOSIS; ELECTROENCEPHALOGRAPHY; FLUID BALANCE; HEMODYNAMICS; HUMAN; HYDROCEPHALUS; INTENSIVE CARE; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; INTUBATION; LUMBAR PUNCTURE; NOSE FEEDING; PATIENT MONITORING; PRIORITY JOURNAL; RESPIRATORY CARE; REVIEW; SEIZURE; SEPTIC SHOCK;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BRAIN DISEASES; COMMUNITY-ACQUIRED INFECTIONS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; HUMANS; INTENSIVE CARE; MENINGITIS, BACTERIAL; SPINAL PUNCTURE;

EID: 30044451464     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra052116     Document Type: Review

References (61)

1. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-59. [Erratum, N Engl J Med 2005;352:950.]
2. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997;337:970-6.
3. Attia J, Hatala R, Cook DJ, Wong JG. The rational clinical examination: does this adult patient have acute meningitis? JAMA 1999;282:175-81.
4. Dodge PR, Swartz MN. Bacterial meningitis - a review of selected aspects. II. Special neurologic problems, postmeningitic complications and clinicopathological correlations. N Engl J Med 1965;272:954-60.
5. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med 1993;328:21-8.
6. Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsdottir H, Gudmundsson S. Acute bacterial meningitis in adults: a 20-year overview. Arch Intern Med 1997;157:425-30.
7. Hussein AS, Shafran SD. Acute bacterial meningitis in adults: a 12-year review. Medicine (Baltimore) 2000;79:360-8.
8. Tunkel AR. Bacterial meningitis. Philadelphia: Lippincott Williams & Wilkens, 2001.
9. van Crevel H, Hijdra A, de Gans J. Lumbar puncture and the risk of herniation: when should we first perform CT? J Neurol 2002;249:129-37.
10. Hasbun R, Abrahams J, Jekel J, Quag-liarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001;345:1727-33.
11. Oliver WJ, Shope TC, Kuhns LR. Fatal lumbar puncture: fact versus fiction - an approach to a clinical dilemma. Pediatrics 2003;112:174-6.
12. Winkler F, Kastenbauer S, Yousry TA, Maerz U, Pfister HW. Discrepancies between brain CT imaging and severely raised intracranial pressure proven by ventriculostomy in adults with pneumococcal meningitis. J Neurol 2002;249:1292-7.
13. van de Beek D, de Gans J. Prognostic factors in adults with bacterial meningitis. N Engl J Med 2005;352:514.
14. Fishman RA. Cerebrospinal fluid in diseases of the nervous system. Philadelphia: Saunders, 1992.
15. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998;129:862-9.
16. Proulx N, Frechette D, Toye B, Chan J, Kravcik S. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005;98:291-8.
17. Spanos A, Harrell FE Jr, Durack DT. Differential diagnosis of acute meningitis: an analysis of the predictive value of initial observations. JAMA 1989;262:2700-7.
18. Rådström P, Bäckman A, Qian N, Kragsbjerg P, Påhlson C, Olcén P. Detection of bacterial DNA in cerebrospinal fluid by an assay for simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and streptococci using a seminested PCR strategy. J Clin Microbiol 1994;32:2738-44.
19. Schuurman T, de Boer RF, Kooistra-Smid AM, van Zwet AA. Prospective study of use of PCR amplification and sequencing of 16S ribosomal DNA from cerebrospinal f luid for diagnosis of bacterial meningitis in a clinical setting. J Clin Microbiol 2004;42:734-40.
20. van de Beek D, de Gans J, Spanjaard L, Vermeulen M, Dankert J. Antibiotic guidelines and antibiotic use in adult bacterial meningitis in The Netherlands. J Antimicrob Chemother 2002;49:661-6.
21. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39:1267-84.
22. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-24.
23. Fraser A, Gafter-Gvili A, Paul M, Leibovici L. Antibiotics for preventing meningococcal infections. Cochrane Database Syst Rev 2005;1:CD004785.
24. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347:1549-56.
25. van de Beek D, de Gans J. Dexamethasone and pneumococcal meningitis. Ann Intern Med 2004;141:327.
26. van de Beek D, de Gans J, McIntyre P, Prasad K. Steroids in adults with bacterial meningitis: a systematic review. Lancet Infect Dis 2004;4:139-43.
27. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862-71.
28. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348:727-34.
29. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev 2003;3:CD004305.
30. Lutsar I, Friedland IR, Jafri HS, et al. Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis. J Antimicrob Chemother 2003;52:651-5.
31. Wijdicks EFM. The clinical practice of critical care neurology. 2nd ed. New York: Oxford University Press, 2003.
32. Pfister HW, Feiden W, Einhaupl KM. Spectrum of complications during bacterial meningitis in adults: results of a prospective clinical study. Arch Neurol 1993;50:575-81.
33. Oates-Whitehead R, Maconochie I, Baumer H, Stewart M. Fluid therapy for acute bacterial meningitis. Cochrane Database Syst Rev 2005;3:CD004786.
34. Harrigan MR. Cerebral salt wasting syndrome: a review. Neurosurgery 1996;38:152-60.
35. Täuber MG, Sande E, Fournier MA, Tureen JH, Sande MA. Fluid administration, brain edema, and cerebrospinal fluid lactate and glucose concentrations in experimental Escherichia coli meningitis. J Infect Dis 1993;168:473-6.
36. Angstwurm K, Reuss S, Freyer D, et al. Induced hypothermia in experimental pneumococcal meningitis. J Cereb Blood Flow Metab 2000;20:834-8.
37. Deng H, Han HS, Cheng D, Sun GH, Yenari MA. Mild hypothermia inhibits inflammation after experimental stroke and brain inflammation. Stroke 2003;34:2495-501.
38. Koedel U, Scheld WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2002;2:721-36.
39. Lorenzl S, Koedel U, Pfister HW. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat. Crit Care Med 1996;24:1874-80.
40. Möller K, Skinhoj P, Knudsen GM, Larsen FS. Effect of short-term hyperventilation on cerebral blood flow autoregulation in patients with acute bacterial meningitis. Stroke 2000;31:1116-22.
41. Paul R, Koedel U, Pfister HW. Reduction of intracranial pressure by nimodipine in experimental pneumococcal meningitis. Crit Care Med 2000;28:2552-6.
42. Grande PO, Myhre EB, Nordstrom CH, Schliamser S. Treatment of intracranial hypertension and aspects on lumbar dural puncture in severe bacterial meningitis. Acta Anaesthesiol Scand 2002;46:264-70.
43. Lindvall P, Ahlm C, Ericsson M, Gothefors L, Naredi S, Koskinen LO. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis 2004;38:384-90.
44. Mitchell WG. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. Epilepsia 1996;37: Suppl 1:S74-S80.
45. Weststrate W, Hijdra A, de Gans J. Brain infarcts in adults with bacterial meningitis. Lancet 1996;347:399.
46. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults - spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003;126:1015-25.
47. DiNubile MJ, Boom WH, Southwick FS. Septic cortical thrombophlebitis. J Infect Dis 1990;161:1216-20.
48. Levi M, van der Poll T, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004;109:2698-704.
49. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791-8.
50. Dill SR, Cobbs CG, McDonald CK. Subdural empyema: analysis of 32 cases and review. Clin Infect Dis 1995;20:372-86.
51. Gates GA, Miyamoto RT. Cochlear implants. N Engl J Med 2003;349:421-3.
52. Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995;39:1988-92.
53. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991;35:2467-72.
54. van de Beek D, Schmand B, de Gans J, et al. Cognitive impairment in adults with good recovery after bacterial meningitis. J Infect Dis 2002;186:1047-52.
55. Jiang X, Mu D, Manabat C, et al. Differential vulnerability of immature murine neurons to oxygen-glucose deprivation. Exp Neurol 2004;190:224-32.
56. Kastenbauer S, Koedel U, Weih F, Ziegler-Heitbrock L, Pfister HW. Protective role of NF-kappaB1 (p50) in experimental pneumococcal meningitis. Eur J Pharmacol 2004;498:315-8. [Erratum, Eur J Pharmacol 2004;504:235.]
57. Bifrare YD, Kummer J, Joss P, Tauber MG, Leib SL. Brain-derived neurotrophic factor protects against multiple forms of brain injury in bacterial meningitis. J Infect Dis 2005;191:40-5.
58. Kim KS. Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci 2003;4:376-85.
59. Swartz MN. Bacterial meningitis - a view of the past 90 years. N Engl J Med 2004;351:1826-8.
60. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of proteinpolysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46.
61. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005;54(RR-7):1-21.